T790M mutations identified by circulating tumor DNA test in lung adenocarcinoma patients who progressed on first-line epidermal growth factor receptor-tyrosine kinase inhibitors

Background: Plasma circulating tumor deoxyribonucleic acid (ctDNA) test is an alternative method to detect the T790M mutation. Compared to conventional tumor rebiopsy, ctDNA possesses several advantages including less invasive, faster, lower costs, and having minimal risk of complications for patien...

Descripció completa

Dades bibliogràfiques

Autors principals:	Vinodini Merinda, Gatot Soegiarto, Laksmi Wulandari
Format:	Artigo
Idioma:	Inglês
Publicat:	Wolters Kluwer Medknow Publications 2020-01-01
Col·lecció:	Lung India
Matèries:	t790m mutation first-line epidermal growth factor receptor-tyrosine kinase inhibitors lung adenocarcinoma plasma circulating tumor deoxyribonucleic acid
Accés en línia:	http://www.lungindia.com/article.asp?issn=0970-2113;year=2020;volume=37;issue=1;spage=13;epage=18;aulast=Merinda
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!